CALL US:
022-6101 1700
sales@saffronmedia.in
HOME
NEWS
INGREDIENT MART
EVENTS
TOPICS
INTERVIEW
EDIT
News
IDMA urges Centre to introduce prospective batch pricing towards compliance to DPCO guidelines
Shardul Nautiyal, Mumbai
February 16 , 2023
The Indian Drug Manufacturers’ Association (IDMA) has urged the Department of Pharmaceuticals (DoP) that the applicability of ceiling prices should be done from the immediate prospective batch towards compliance to Drug Prices Control Order (DPCO-2013).
Once done, this can be followed with submission of Form V by the manufacturers in the Integrated Pharmaceutical Database Management System (IPDMS 2.0) which should be considered as information submitted officially, the IDMA recommended.
As of today, ceiling prices once notified are effective immediately. Intimating 8 lakh pharmacies overnight and asking them to comply immediately with the reduced price is beyond the scope and reach of any company.
Each company intimates its C&F/super stockists and stockists immediately and also submits Form II and V price lists on the IPDMS site as per the DPCO guidelines. Even if a single strip of a scheduled formulation is found at a retail counter with a price higher than the notified price, the company is issued notices for overcharging despite the fact that the company has no direct agreement with the retailer.
IDMA members have also voiced their concern that there are multiple notifications on record regarding the process to call back the stocks and revise the prices. The National Pharmaceutical Pricing Authority (NPPA) and DoP should clarify in this regard well in advance so arrangements can be made by the companies to revise prices as per guidelines and to avoid getting embroiled into overcharging issues.
NPPA has introduced IPDMS 2.0 towards creating an authentic database of information on products, prices, production and sale of scheduled, non-scheduled formulations and active pharmaceutical ingredients (APIs). It also aims to optimize synergies in operations by providing a single window for submissions of various forms as mandated under the DPCO - 2013.
Share This Story
Leave a Reply
Your name (required)
Your email (required)
Website (required)
CommenT
Enter Code (Required)
INGREDIENT MART
RECENT NEWS
2024 a landmark year for Indian pharma with advancements in manufacturing, tech & healthcare access
Parliamentary panel asks DoP to take up issues related to schemes with state agencies
Parliamentary panel expresses dismay on tardy progress of Medical Devices Parks under DoP scheme
Stakeholders concerned over delay in officially lifting ban on methylcobalamin
More News...
TOPICS
Plant-based functional foods and phytochemicals
That foods might provide therapeutic benefits is clearly not a new concept. ...
More News...
MAIN LINKS
OUR SERVICES
OTHER PRODUCTS
ONLINE MEDIA
About Us
Contact Us
News Archives
Product Finder
Features and Articles
News
Chronicle Pharmabiz
Food & Bevergae News
Ingredients South Asia
Media Information
Rate Card
Advertise
Copyright © 2023 Saffron Media Pvt Ltd. All Rights Reserved.
Best View in Chrome (103.0) or Firefox (90.0)